Publications
Contact
FR
Products
PRESCRIPTION
Therapy-07
DRUG-FREE
Therapy-16
RIZN
Plenty Natural
Company
Science
Investors
Clinical trials
Products
PRESCRIPTION l Therapy-7
DRUG-FREE l Therapy-16
Hair Loss Rx Consult
RIZN
Plenty Natural
Company
Science
Investors
Clinical trials
<?php
'10'
Publications
Corporate, science and informational news
Keep up to date with the latest developments at Triple Hair! Check out our various publications to stay abreast of our scientific advances and the company’s growth.
All
ALOPECIA
Corporate
In the medias
Science
All
ALOPECIA
Corporate
In the medias
Science
READ MORE
October 17, 2023
Corporate
Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical
READ MORE
July 27, 2023
Corporate
OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel
READ MORE
June 28, 2023
Corporate
Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada
READ MORE
June 22, 2023
ALOPECIA
Can anxiety or even mental health affect hair loss?
READ MORE
June 19, 2023
Corporate
Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S.
READ MORE
June 14, 2023
Corporate
Triple Hair Group Reports Positive Results from Safety Studies on its Therapy-07 Prescription Drug
READ MORE
August 11, 2022
Corporate
New Possibilities in Hair Loss Prescription Therapies
READ MORE
June 21, 2022
Corporate
Triple Hair Group announces strategic arrangement with leading US compounding company Pharmacy Solutions
READ MORE
March 24, 2022
Corporate
Triple Hair Group announces the launch of Plenty Natural™
READ MORE
December 7, 2021
Corporate
Triple Hair Group announces the launch of RIZN™
×
Looking to invest?
Type of investor
Individual
Accredited Investor
Company
Other